Treatment of Localized Scleroderma with Limited Skin Involvement Reaching to the Dermis
Clinical Scenario
This protocol applies to localized scleroderma in which skin involvement reaches to the dermis but does not extend into the subcutaneous fat, fascia, muscle, joints, or bones — and where involvement is not widespread. This specific depth and extent of involvement defines the therapeutic approach.
Why Depth of Involvement Matters
For cases limited to the skin, guidelines primarily recommend topical therapy. Certain phototherapy modalities appropriate for superficial subtypes are not considered suitable when deeper structures are affected. Accurate characterisation of lesion depth is therefore essential before selecting treatment.
Treatment Approach
First-line management in the active phase centres on topical therapy, with phototherapy representing a well-supported additional or alternative option specifically for this limited subtype.
Treatment goal: Reduction of skin sclerosis — effectiveness is typically assessed over a period of 8 to 12 weeks from initiation.
References
DOI: 10.1111/ddg.15328
- For cases of limited skin involvement, the guideline primarily recommends therapy with topical corticosteroids.
- In contrast, UV radiation is not suitable for types involving deeper structures such as adipose tissue, fascia, muscles, and bones.
- We recommend topical treatment for LoS with limited skin involvement during the active phase using medium- to high-potency glucocorticosteroids once daily.
- We recommend using medium-dose UVA1 phototherapy as the first-line phototherapy for limited subtypes of LoS.
- When assessing the effectiveness of the chosen therapeutic concept, it should be noted that the reduction of sclerosis typically takes at least 8 to 12 weeks in most cases.
View source ↗